Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 20;188(6):1524-1544.e22.
doi: 10.1016/j.cell.2025.01.031. Epub 2025 Feb 11.

Distinct mismatch-repair complex genes set neuronal CAG-repeat expansion rate to drive selective pathogenesis in HD mice

Affiliations

Distinct mismatch-repair complex genes set neuronal CAG-repeat expansion rate to drive selective pathogenesis in HD mice

Nan Wang et al. Cell. .

Abstract

Huntington's disease (HD) modifiers include mismatch-repair (MMR) genes, but their connections to neuronal pathogenesis remain unclear. Here, we genetically tested 9 HD genome-wide association study (GWAS)/MMR genes in mutant Huntingtin (mHtt) mice with 140 inherited CAG repeats (Q140). Knockout (KO) of genes encoding a distinct MMR complex either strongly (Msh3 and Pms1) or moderately (Msh2 and Mlh1) rescues phenotypes with early onset in striatal medium-spiny neurons (MSNs) and late onset in the cortical neurons: somatic CAG-repeat expansion, transcriptionopathy, and mHtt aggregation. Msh3 deficiency ameliorates open-chromatin dysregulation in Q140 neurons. Mechanistically, the fast linear rate of mHtt modal-CAG-repeat expansion in MSNs (8.8 repeats/month) is drastically reduced or stopped by MMR mutants. Msh3 or Pms1 deficiency prevents mHtt aggregation by keeping somatic MSN CAG length below 150. Importantly, Msh3 deficiency corrects synaptic, astrocytic, and locomotor defects in HD mice. Thus, Msh3 and Pms1 drive fast somatic mHtt CAG-expansion rates in HD-vulnerable neurons to elicit repeat-length/threshold-dependent, selective, and progressive pathogenesis in vivo.

Keywords: ATAC-seq; CAG repeat; Huntingtin; Huntington's disease; Mlh1; Msh2; Msh3; Pms1; RNA-seq; aggregate; chromatin; cortex; mismatch repair; neurons; rate; repeat expansion; repeat instability; selective vulnerability; striatum; threshold.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests X.W.Y. is a Scientific Advisory Board member for Lyterian and Ophidion and a consultant/seminar speaker for Ionis, Biogen, Novartis, Roche, LifeEdit, PTC, Ascidian, Sangamo, and Forbion. P.L. served as an occasional consultant for The Bioinformatics CRO, Vynance, and FOXO Technologies, Inc. S.H. works for Altos Labs, UK.

Update of

References

    1. Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, et al. (2014). Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 10, 204–216. 10.1038/nrneurol.2014.24. - DOI - PubMed
    1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. The Huntington’s Disease Collaborative Research Group. (1993). Cell 72, 971–983. 10.1016/0092-8674(93)90585-e. - DOI - PubMed
    1. Vonsattel JP, and DiFiglia M (1998). Huntington disease. Journal of neuropathology and experimental neurology 57, 369–384. - PubMed
    1. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, and Aronin N (1997). Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990–1993. 10.1126/science.277.5334.1990. - DOI - PubMed
    1. Arrasate M, and Finkbeiner S (2012). Protein aggregates in Huntington’s disease. Exp Neurol 238, 1–11. 10.1016/j.expneurol.2011.12.013. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources